Skip to main content
Clinical Trials/CTRI/2021/06/034474
CTRI/2021/06/034474
Not yet recruiting
未知

Prevalence, predisposing factors and management of Head and Neck Lymphedema inpatients following treatment for Head and Neck Cancer. (HeNLy-1 Study)

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Memorial Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. All patients who have completed definitive HNC treatment
  • 2\. Age \> 18 years
  • 3\. No current evidence of cancer.
  • 4\. Time since the last cancer treatment should be at least 6 months
  • 5\. At least some part of the definitive treatment must have been taken at Tata Memorial Hospital

Exclusion Criteria

  • 1\. Having metastatic cancer or any other active cancer, or
  • 2\. Unable to understand the informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials